Literature DB >> 8459243

Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease.

D Caparros-Lefebvre1, S Blond, P Vermersch, N Pécheux, J D Guieu, H Petit.   

Abstract

Chronic thalamic stimulation was performed in 10 Parkinsonian patients with disabling tremor and poor response to drug therapy. During the stereotactic procedure, an electrode was introduced in the ventralis intermediate nucleus of the thalamus. Test stimulation was performed during the intra-operative procedure and a few days after surgery using an external stimulator. When tremor was obviously reduced by thalamic stimulation, an internal stimulator was implanted under the clavicle. Tremor was initially suppressed in all cases and reappeared whenever stimulation was stopped. Patients were followed for 22 to 34 months. Tremor was controlled in eight cases but reappeared after three months in two cases. Levodopa induced dyskinesias were observed before electrode implantation in 5 cases. They consisted of peak-dose choreic or ballistic dyskinesias in 4 cases and biphasic dystonic dyskinesias in 3 cases. Peak-dose dyskinesias were greatly improved or suppressed in all cases. Biphasic dyskinesias were improved in 2 cases. Thalamic stimulation was well tolerated. Mild dystonic hand posture related to the deep brain stimulation was observed in one case. No neuropsychological side-effects were noted. Thalamic stimulation could prove to be an adequate treatment for resistant tremor and levodopa induced dyskinesias.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459243      PMCID: PMC1014859          DOI: 10.1136/jnnp.56.3.268

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

Review 1.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex.

Authors:  G E Alexander; M R DeLong; P L Strick
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

Review 2.  Lessons from stereotaxic surgery using microelectrode techniques in understanding parkinsonism.

Authors:  H Narabayashi
Journal:  Mt Sinai J Med       Date:  1988-01

3.  Physiological study of presumed ventralis intermedius neurons in the human thalamus.

Authors:  C Ohye; H Narabayashi
Journal:  J Neurosurg       Date:  1979-03       Impact factor: 5.115

4.  Suppression of intention tremor by contingent deep-brain stimulation.

Authors:  J Brice; L McLellan
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

5.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

6.  Levodopa-induced dyskinesia and thalamotomy.

Authors:  H Narabayashi; F Yokochi; Y Nakajima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

7.  [Treatment of Parkinson tremor by chronic stimulation of the ventral intermediate nucleus of the thalamus].

Authors:  A L Benabid; P Pollak; M Hommel; J M Gaio; J de Rougemont; J Perret
Journal:  Rev Neurol (Paris)       Date:  1989       Impact factor: 2.607

8.  Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea.

Authors:  A R Crossman; I J Mitchell; M A Sambrook; A Jackson
Journal:  Brain       Date:  1988-10       Impact factor: 13.501

9.  Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.

Authors:  I J Mitchell; A J Cross; M A Sambrook; A R Crossman
Journal:  Neurosci Lett       Date:  1986-01-02       Impact factor: 3.046

10.  L-dopa in Parkinsonism and the influence of previous thalamotomy.

Authors:  R C Hughes; J G Polgar; D Weightman; J N Walton
Journal:  Br Med J       Date:  1971-01-02
View more
  14 in total

1.  Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex.

Authors:  D Caparros-Lefebvre; S Blond; M P Feltin; P Pollak; A L Benabid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Morphological differences in Parkinson's disease with and without rest tremor.

Authors:  David H Benninger; Sebastian Thees; Spyros S Kollias; Claudio L Bassetti; Daniel Waldvogel
Journal:  J Neurol       Date:  2009-02-04       Impact factor: 4.849

3.  Usefulness of pallidotomy in advanced Parkinson's disease.

Authors:  F Johansson; J Malm; E Nordh; M Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

4.  A wirelessly powered and controlled device for optical neural control of freely-behaving animals.

Authors:  Christian T Wentz; Jacob G Bernstein; Patrick Monahan; Alexander Guerra; Alex Rodriguez; Edward S Boyden
Journal:  J Neural Eng       Date:  2011-06-23       Impact factor: 5.379

5.  Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.

Authors:  P Limousin; J D Speelman; F Gielen; M Janssens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

Review 6.  Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease.

Authors:  P Limousin-Dowsey; P Pollak; N Van Blercom; P Krack; A Benazzouz; A Benabid
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

7.  Contemporaneous bilateral postero-ventral pallidotomy for early onset "juvenile type" Parkinson's disease. Case report.

Authors:  R P Iacono; R R Lonser; S Yamada
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 8.  Methods of managing levodopa-induced dyskinesias.

Authors:  L T Giron; W C Koller
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

9.  Which factors predict cognitive decline in Parkinson's disease?

Authors:  D Caparros-Lefebvre; N Pécheux; V Petit; A Duhamel; H Petit
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

Review 10.  Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Gemma Navarro; Annalisa Pinna; Irene Reyes-Resina
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.